GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...
It stands out in a region where Amish farms and hills covered with second-growth red-oak woods, parks, and hiking trails ...
From the end of November Market data will no longer be displayed here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback